Insider Profile
Cavey, George Ross
1
Companies Filed At
0
Open-Market Buys (2yr)
Buy Value (2yr, open-market)
Apr 27, 2026
Most Recent Trade
Date Company Role Nature Dir. Shares Price Value Score
Apr 27, 2026 $DEF
Defiance Silver Corp.
Exercise Buy 27,083 38
Apr 27, 2026 $DEF
Defiance Silver Corp.
Exercise Sell 27,083 38
Jun 20, 2025 $DEF
Defiance Silver Corp.
Open Market Sell 100,000 $0.25 $25K 38
Jun 20, 2025 $DEF
Defiance Silver Corp.
Open Market Sell 50,000 38
Apr 22, 2025 $DEF
Defiance Silver Corp.
Exercise Buy 81,250 38
Apr 22, 2025 $DEF
Defiance Silver Corp.
Exercise Sell 81,250 38
Apr 12, 2024 $DEF
Defiance Silver Corp.
Comp. Grant Buy 400,000 $0.18 $72K 38
Apr 12, 2024 $DEF
Defiance Silver Corp.
Comp. Grant Buy 81,250 38
Apr 12, 2024 $DEF
Defiance Silver Corp.
Comp. Grant Buy 400,000 $0.18 $72K 38
Apr 12, 2024 $DEF
Defiance Silver Corp.
Comp. Grant Buy 81,250 38
Apr 12, 2024 $DEF
Defiance Silver Corp.
Expiry Buy 125,000 38
Apr 12, 2024 $DEF
Defiance Silver Corp.
Comp. Grant Buy 81,250 38
Apr 12, 2024 $DEF
Defiance Silver Corp.
Comp. Grant Buy 400,000 $0.18 $72K 38
Jan 31, 2023 $DEF
Defiance Silver Corp.
Corp. Event Sell 27,083 38
Jan 31, 2023 $DEF
Defiance Silver Corp.
Comp. Grant Buy 81,250 38
Jan 31, 2023 $DEF
Defiance Silver Corp.
Corp. Event Sell 27,083 38
Jan 31, 2023 $DEF
Defiance Silver Corp.
Comp. Grant Buy 230,000 38
Jan 31, 2023 $DEF
Defiance Silver Corp.
Corp. Event Buy 27,083 38
Jan 31, 2023 $DEF
Defiance Silver Corp.
Corp. Event Buy 27,083 38
Dec 12, 2022 $DEF
Defiance Silver Corp.
Other Buy 102,565 $0.20 $20K 38
Mar 09, 2022 $DEF
Defiance Silver Corp.
Corp. Event Buy 27,083 38
Mar 09, 2022 $DEF
Defiance Silver Corp.
Corp. Event Sell 27,083 38
Jan 31, 2022 $DEF
Defiance Silver Corp.
Comp. Grant Buy 243,750 38
Jan 31, 2022 $DEF
Defiance Silver Corp.
Comp. Grant Buy 81,250 38
Nov 05, 2020 $DEF
Defiance Silver Corp.
Other Sell 38
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.